Glenmede Trust CO Na Innoviva, Inc. Transaction History

Glenmede Trust CO Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $12,390 - $16,573	-1,328 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $1,115 - $1,564	108 Added 8.85%	1,328 $13,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $4,377 - $5,814	381 Added 45.41%	1,220 $17,000
Q4 2019 Feb 12, 2020	BUY	$10.28 - $14.38 $4,482 - $6,269	436 Added 108.19%	839 $11,000
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $1,276 - $1,847	127 Added 46.01%	403 $4,000
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $18,755 - $27,482	-1,370 Reduced 83.23%	276 $3,000
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $19,795 - $25,892	1,418 Added 621.93%	1,646 $27,000
Q2 2018 Aug 15, 2018	BUY	$13.44 - $17.59 $3,064 - $4,010	228 New	228 $3,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.